These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 34284566)

  • 1. Common anti-oxidant vitamin C as an anti-infective agent with remedial role on SARS-CoV-2 infection. An update.
    Michailides C; Velissaris D
    Monaldi Arch Chest Dis; 2021 Jul; 91(4):. PubMed ID: 34284566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
    Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
    J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19.
    Holford P; Carr AC; Jovic TH; Ali SR; Whitaker IS; Marik PE; Smith AD
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19.
    Mrityunjaya M; Pavithra V; Neelam R; Janhavi P; Halami PM; Ravindra PV
    Front Immunol; 2020; 11():570122. PubMed ID: 33117359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: The Immune Responses and Clinical Therapy Candidates.
    Zhand S; Saghaeian Jazi M; Mohammadi S; Tarighati Rasekhi R; Rostamian G; Kalani MR; Rostamian A; George J; Douglas MW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
    Devaux CA; Rolain JM; Colson P; Raoult D
    Int J Antimicrob Agents; 2020 May; 55(5):105938. PubMed ID: 32171740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
    Conzelmann C; Müller JA; Perkhofer L; Sparrer KM; Zelikin AN; Münch J; Kleger A
    Clin Med (Lond); 2020 Nov; 20(6):e218-e221. PubMed ID: 32863274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses.
    Sengupta S; Bhattacharyya D; Kasle G; Karmakar S; Sahu O; Ganguly A; Addya S; Das Sarma J
    Front Cell Infect Microbiol; 2021; 11():729622. PubMed ID: 34513735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).
    Hsue VB; Itamura K; Wu AW; Illing EA; Sokoloski KJ; Weaver BA; Anthony BP; Hughes N; Ting JY; Higgins TS
    Adv Exp Med Biol; 2021; 1327():169-189. PubMed ID: 34279838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic.
    Darenskaya M; Kolesnikova L; Kolesnikov S
    Curr Pharm Des; 2021; 27(13):1618-1627. PubMed ID: 33618639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
    Barh D; Tiwari S; Weener ME; Azevedo V; Góes-Neto A; Gromiha MM; Ghosh P
    Comput Biol Med; 2020 Nov; 126():104051. PubMed ID: 33131530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
    González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico.
    Hassan Y; Ogg S; Ge H
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.